PlainRecalls
FDA Drug Low Class III Terminated

Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96

Reported: September 27, 2023 Initiated: September 7, 2023 #D-1172-2023

Product Description

Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96

Reason for Recall

Subpotent: Out of Specification result observed for low assay

Details

Units Affected
69,707 cartons
Distribution
Nationwide wide in the USA
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France NDC 47335-506-96. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 69,707 cartons.
Why was this product recalled?
Subpotent: Out of Specification result observed for low assay
Which agency issued this recall?
This recall was issued by the FDA Drug on September 27, 2023. Severity: Low. Recall number: D-1172-2023.